IMMUNOGENICITY AND SAFETY PROFILES OF GENETIC VACCINES AGAINST HUMAN HER-2/NEU IN CYNOMOLGUS MONKEYS

被引：0
|
作者：
Ko, Hyun-Jeong [1 ]
Kim, Yeon-Jeong [1 ]
Kim, Yun-Sun [1 ]
Kim, Jong-Mook [2 ]
Ho, Seong-Huyn [2 ]
Jeong, Jae-Gyun [2 ]
Oh, Sung-Min [2 ]
Chae, Jin-A [2 ]
Kim, Choong-Yong [3 ]
Lee, Pill Soo [3 ]
Kang, Chang-Yuil [1 ]
机构：
[1] Seoul Natl Univ, Coll Pharm, Inst Pharmaceut Sci, Immunol Lab, Seoul 151742, South Korea
[2] ViroMed Co Ltd, Seoul 151818, South Korea
[3] Korea Inst Toxicol, Div Nonclin Studies, Taejon 305600, South Korea
来源：
JOURNAL OF GENE MEDICINE | 2009年 / 11卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1190 / 1190
页数：1
相关论文
共 50 条
  • [1] Immunogenicity and safety profiles of genetic vaccines against human Her-2/neu in cynomolgus monkeys
    Ko, H-J
    Kim, Y-J
    Kim, Y-S
    Kim, J-M
    Ho, S-H
    Jeong, J-G
    Oh, S-M
    Chae, J-A
    Kim, C-Y
    Lee, P-S
    Kang, C-Y
    GENE THERAPY, 2008, 15 (20) : 1351 - 1360
  • [2] Immunogenicity and safety profiles of genetic vaccines against human Her-2/neu in cynomolgus monkeys
    H-J Ko
    Y-J Kim
    Y-S Kim
    J-M Kim
    S-H Ho
    J-G Jeong
    S-M Oh
    J-A Chae
    C-Y Kim
    P-S Lee
    C-Y Kang
    Gene Therapy, 2008, 15 : 1351 - 1360
  • [3] Telomerase and HER-2/neu as targets of genetic cancer vaccines in dogs
    Peruzzi, Daniela
    Mesiti, Giuseppe
    Ciliberto, Gennaro
    La Monica, Nicola
    Aurisicchio, Luigi
    VACCINE, 2010, 28 (05) : 1201 - 1208
  • [4] HER-2/neu as a target for cancer vaccines
    Baxevanis, Constantin N.
    Voutsas, Ioannis F.
    Gritzapis, Angelos D.
    Perez, Sonia A.
    Papamichail, Michael
    IMMUNOTHERAPY, 2010, 2 (02) : 213 - 226
  • [5] Vaccination against Her-2/neu, with focus on peptide-based vaccines
    Tobias, J.
    Garner-Spitzer, E.
    Drinic, M.
    Wiedermann, U.
    ESMO OPEN, 2022, 7 (01)
  • [6] Activity of DNA vaccines encoding self or heterologous Her-2/neu in Her-2 or neu transgenic mice
    Jacob, Jennifer
    Radkevich, Olga
    Forni, Guido
    Zielinski, John
    Shim, David
    Jones, Richard F.
    Wei, Wei-Zen
    CELLULAR IMMUNOLOGY, 2006, 240 (02) : 96 - 106
  • [7] Immunogenic HER-2/neu peptides as tumor vaccines
    Baxevanis, CN
    Sotiriadou, NN
    Gritzapis, AD
    Sotiropoulou, PA
    Perez, SA
    Cacoullos, NT
    Papamichail, M
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (01) : 85 - 95
  • [8] Immunogenic HER-2/neu peptides as tumor vaccines
    Constantin N. Baxevanis
    Nectaria N. Sotiriadou
    Angelos D. Gritzapis
    Panagiota A. Sotiropoulou
    Sonia A. Perez
    Nike T. Cacoullos
    Michael Papamichail
    Cancer Immunology, Immunotherapy, 2006, 55 : 85 - 95
  • [9] Clinical trials of HER-2/neu-specific vaccines
    Murray, JL
    Przepiorka, D
    Ioannides, CG
    SEMINARS IN ONCOLOGY, 2000, 27 (06) : 71 - 75
  • [10] Preclinical HER-2 vaccines: from rodent to human HER-2
    Lollini, Pier-Luigi
    De Giovanni, Carla
    Nanni, Patrizia
    FRONTIERS IN ONCOLOGY, 2013, 3
12345